{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:40:55Z","timestamp":1793403655087,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,3]],"date-time":"2023-12-03T00:00:00Z","timestamp":1701561600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Heart Journal"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ihj.2023.12.001","type":"journal-article","created":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T11:53:51Z","timestamp":1712577231000},"page":"S121-S129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"S1","title":["Apolipoprotein B - An ideal biomarker for atherosclerosis?"],"prefix":"10.1016","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4330-666X","authenticated-orcid":false,"given":"Kavita","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorairaj","family":"Prabhakaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ihj.2023.12.001_bib1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.atherosclerosis.2019.12.009","article-title":"Data-driven multivariate population subgrouping via lipoprotein phenotypes versus apolipoprotein B in the risk assessment of coronary heart disease","volume":"294","author":"Ohukainen","year":"2020","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.ihj.2023.12.001_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003062","article-title":"Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: a multivariable Mendelian randomisation analysis","volume":"17","author":"Richardson","year":"2020","journal-title":"PLoS Med"},{"issue":"24","key":"10.1016\/j.ihj.2023.12.001_bib3","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1093\/eurheartj\/ehs431","article-title":"Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction","volume":"34","author":"Jorgensen","year":"2013","journal-title":"Eur Heart J"},{"issue":"10244","key":"10.1016\/j.ihj.2023.12.001_bib4","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0140-6736(20)30543-2","article-title":"Variations between women and men in risk factors, treatments, cardiovascular disease incidence, and death in 27 high-income, middle-income, and low-income countries (PURE): a prospective cohort study","volume":"396","author":"Walli-Attaei","year":"2020","journal-title":"Lancet"},{"issue":"20","key":"10.1016\/j.ihj.2023.12.001_bib5","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1001\/jama.2020.21749","article-title":"Behavioral counseling interventions to promote a healthy diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors: US preventive services task force recommendation statement","volume":"324","author":"Uspst","year":"2020","journal-title":"JAMA"},{"issue":"9438","key":"10.1016\/j.ihj.2023.12.001_bib6","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ihj.2023.12.001_bib7","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/ana.24936","article-title":"Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: a more than 20-year follow-up of the Swedish AMORIS cohort","volume":"81","author":"Mariosa","year":"2017","journal-title":"Ann Neurol"},{"issue":"12","key":"10.1016\/j.ihj.2023.12.001_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003853","article-title":"Long-term risk of a major cardiovascular event by apoB, apoA-1, and the apoB\/apoA-1 ratio-Experience from the Swedish AMORIS cohort: a cohort study","volume":"18","author":"Walldius","year":"2021","journal-title":"PLoS Med"},{"issue":"11","key":"10.1016\/j.ihj.2023.12.001_bib9","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/ejcn.2016.89","article-title":"A systematic review and meta-analysis of randomized controlled trials of the effect of barley beta-glucan on LDL-C, non-HDL-C and apoB for cardiovascular disease risk reduction(i-iv)","volume":"70","author":"Ho","year":"2016","journal-title":"Eur J Clin Nutr"},{"issue":"12","key":"10.1016\/j.ihj.2023.12.001_bib10","first-page":"22","article-title":"APO B\/APO AI ratio with coronary artery disease with normal lipid profile in the Indian population","volume":"65","author":"Modi","year":"2017","journal-title":"J Assoc Phys India"},{"key":"10.1016\/j.ihj.2023.12.001_bib11","doi-asserted-by":"crossref","unstructured":"Akande JO, Salawu AA, Atiba AS, Oke EO, Akande RO, Oparinde DP, et al. Plasma levels of total cholesterol, high-density lipoprotein-cholesterol, low-density lipoprotein-cholesterol, triglyceride, Apo A-1, and Apo B in patients with Stroke in Ogbomoso, Southwestern Nigeria. J Appl Biol Biotechnoly. 7(3):29\u201335.","DOI":"10.7324\/JABB.2019.70306"},{"issue":"1","key":"10.1016\/j.ihj.2023.12.001_bib12","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000498834","article-title":"Association between the lipid profile and renal dysfunction in the heart failure patients","volume":"44","author":"Zhang","year":"2019","journal-title":"Kidney Blood Press Res"},{"issue":"1","key":"10.1016\/j.ihj.2023.12.001_bib13","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jacl.2019.11.005","article-title":"Apolipoprotein B discordance with low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol in relation to coronary artery calcification in the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"14","author":"Cao","year":"2020","journal-title":"J Clin Lipidol"},{"issue":"1","key":"10.1016\/j.ihj.2023.12.001_bib14","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s43044-021-00150-z","article-title":"The relation between ApoB\/ApoA-1 ratio and the severity of coronary artery disease in patients with acute coronary syndrome","volume":"73","author":"Yaseen","year":"2021","journal-title":"Egypt Heart J"},{"issue":"2","key":"10.1016\/j.ihj.2023.12.001_bib15","first-page":"63","volume":"7","author":"Badrinath","year":"2019"},{"issue":"2","key":"10.1016\/j.ihj.2023.12.001_bib16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3329\/jbsp.v10i2.27164","article-title":"Association of apo B, apo A1 and lipid profile with early onset stroke","volume":"10","author":"Malek","year":"2015","journal-title":"J Bangladesh Soc Physiol"},{"issue":"1","key":"10.1016\/j.ihj.2023.12.001_bib17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3329\/imcj.v9i1.27638","article-title":"Apolipoprotein A-I and B levels in Bangladeshi patients with coronary artery disease","volume":"9","author":"Chowdhury","year":"2016","journal-title":"Ibrahim Med Coll J"},{"issue":"10","key":"10.1016\/j.ihj.2023.12.001_bib18","first-page":"180","article-title":"Of lipid fractions levels with cardiovascular disease","volume":"1","author":"Association","year":"2015","journal-title":"Asian J Pharmaceut Clin Res"},{"issue":"11","key":"10.1016\/j.ihj.2023.12.001_bib19","first-page":"BC09","article-title":"Conventional and advanced lipid parameters in premature coronary artery disease patients in India","volume":"Nov","author":"Bansal","year":"2015","journal-title":"J Clin Diagn Res"},{"issue":"10","key":"10.1016\/j.ihj.2023.12.001_bib20","doi-asserted-by":"crossref","first-page":"224","DOI":"10.22317\/jcms.v3i10.170","article-title":"Role of vitamin D3 level and Apo-B\/Apo-A1 ratio in patients with unstable angina in Kerbala province, Iraq","author":"Al-Tu\u2019ma","year":"2017","journal-title":"J Contemp Med Sci"},{"issue":"2","key":"10.1016\/j.ihj.2023.12.001_bib21","first-page":"20","article-title":"Apo B\/apo A1 ratio: a risk marker in patients with cardiovascular disease","volume":"6","author":"Sathe","year":"2017","journal-title":"Int J Res Med"},{"issue":"4","key":"10.1016\/j.ihj.2023.12.001_bib22","doi-asserted-by":"crossref","first-page":"514","DOI":"10.18231\/j.ijcbr.2019.107","article-title":"Comparison of apolipoprotein levels with conventional Lipid profile parameters in patients with coronary heart disease","volume":"6","author":"Patel","year":"2019","journal-title":"IJCBR"},{"issue":"10","key":"10.1016\/j.ihj.2023.12.001_bib23","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1177\/2047487315569411","article-title":"Apolipoprotein B improves risk assessment of future coronary heart disease in the Framingham Heart Study beyond LDL-C and non-HDL-C","volume":"22","author":"Pencina","year":"2015","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.ihj.2023.12.001_bib24","series-title":"High Apo B\/Apo A-1 Serum Ratio as a Predictor of In-Hospital Major Adverse Cardiovascular Events in Acute Coronary Syndrome Patients","author":"Saputri","year":"2017"},{"issue":"2","key":"10.1016\/j.ihj.2023.12.001_bib25","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jacc.2015.10.055","article-title":"Discordance between apolipoprotein B and LDL-cholesterol in young adults predicts coronary artery calcification: the CARDIA study","volume":"67","author":"Wilkins","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ihj.2023.12.001_bib26","article-title":"Apolipoprotein B\/apolipoprotein A-I ratio a better diagnostic marker of coronary heart disease than conventional LDL\/HDL ratio","volume":"5","author":"Prajapati","year":"2016","journal-title":"Natl J Lab Med"},{"issue":"12","key":"10.1016\/j.ihj.2023.12.001_bib27","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007160","article-title":"Lipoprotein(a) and the apolipoprotein B\/A1 ratio independently associate with surgery for aortic stenosis only in patients with concomitant coronary artery disease","volume":"6","author":"Ljungberg","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"10.1016\/j.ihj.2023.12.001_bib28","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jacl.2017.07.001","article-title":"Apolipoprotein B is associated with carotid atherosclerosis progression independent of individual cholesterol measures in a 9-year prospective study of Multi-Ethnic Study of Atherosclerosis participants","volume":"11","author":"Steffen","year":"2017","journal-title":"J Clin Lipidol"},{"issue":"2","key":"10.1016\/j.ihj.2023.12.001_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212539","article-title":"Apolipoprotein B correlates with intra-plaque necrotic core volume in stable coronary artery disease","volume":"14","author":"Ohwada","year":"2019","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.ihj.2023.12.001_bib30","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1053\/j.ajkd.2018.11.010","article-title":"Lipids, apolipoproteins, and risk of atherosclerotic cardiovascular disease in persons with CKD","volume":"73","author":"Bajaj","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ihj.2023.12.001_bib31","series-title":"Prognostic Value of Serum Lipoprotein (A) and Apo Lipoprotein-B in Diabetics with Myocardial Infarction and Chronic Limb Threatening Ischemia","author":"Mowafy","year":"2020"},{"issue":"6","key":"10.1016\/j.ihj.2023.12.001_bib32","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/clc.23610","article-title":"Prognostic implications of calculated Apo-lipoprotein B in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: outcome is tied to lower cut-points","volume":"44","author":"Ghodsi","year":"2021","journal-title":"Clin Cardiol"},{"issue":"2","key":"10.1016\/j.ihj.2023.12.001_bib33","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1373\/jalm.2016.021006","article-title":"Lipoprotein biomarkers and risk of cardiovascular disease: a laboratory medicine best practices (LMBP) systematic review","volume":"1","author":"Sandhu","year":"2016","journal-title":"J Appl Lab Med"},{"issue":"1","key":"10.1016\/j.ihj.2023.12.001_bib34","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ihj.2022.11.014","article-title":"Novel lipid biomarkers and associated gene polymorphism in young ST-segment elevation myocardial infarction","volume":"75","author":"Muheeb","year":"2023","journal-title":"Indian Heart J"},{"issue":"1","key":"10.1016\/j.ihj.2023.12.001_bib35","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12933-022-01494-9","article-title":"Prognostic significance of metabolomic biomarkers in patients with diabetes mellitus and coronary artery disease","volume":"21","author":"Karagiannidis","year":"2022","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"10.1016\/j.ihj.2023.12.001_bib36","first-page":"L93","article-title":"Association of pro protein convertase subtilisin\/kexin 9, apo B and HbA1c in coronary artery disease with and without diabetes mellitus: life sciences-biochemistry","volume":"12","author":"P K D","year":"2022","journal-title":"Int J Life Sci Pharm Res"},{"issue":"7","key":"10.1016\/j.ihj.2023.12.001_bib37","article-title":"Apolipoprotein B and lipid profile among patients diagnosed with acute myocardial infarction Pakistan","volume":"5","author":"Mustafa","year":"2022","journal-title":"Biomed J"},{"issue":"1","key":"10.1016\/j.ihj.2023.12.001_bib38","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3126\/njh.v19i1.45292","article-title":"Apolipoprotein B and lipid profile among patients diagnosed with acute myocardial infarction","volume":"19","author":"Shrestha","year":"2022","journal-title":"Nepal Heart J"},{"key":"10.1016\/j.ihj.2023.12.001_bib39","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/6403645","article-title":"Correlation between lpa, APO-A, APO-B, and stenosis of middle cerebral artery in patients with cerebral ischemic stroke","volume":"2022","author":"Chen","year":"2022","journal-title":"Emerg Med Int"},{"issue":"1","key":"10.1016\/j.ihj.2023.12.001_bib40","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12944-022-01667-1","article-title":"Circulating growth differentiation factor 15 levels and apolipoprotein B to apolipoprotein A1 ratio in coronary artery disease patients with type 2 diabetes mellitus","volume":"21","author":"Mei","year":"2022","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.ihj.2023.12.001_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.865863","article-title":"Residual risk of coronary atherosclerotic heart disease and severity of coronary atherosclerosis assessed by ApoB and LDL-C in participants with statin treatment: a retrospective cohort study","volume":"13","author":"Yao","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.ihj.2023.12.001_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2022.100436","article-title":"Small dense low-density lipoprotein cholesterol compared to other lipoprotein biomarkers for predicting coronary heart disease among individuals with normal fasting glucose: the Multi-Ethnic Study of Atherosclerosis","volume":"13","author":"Nomura","year":"2023","journal-title":"Am J Prev Cardiol"},{"issue":"3","key":"10.1016\/j.ihj.2023.12.001_bib43","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1161\/ATVBAHA.117.310473","article-title":"APOC3 loss-of-function mutations, remnant cholesterol, low-density lipoprotein cholesterol, and cardiovascular risk: mediation- and meta-analyses of 137 895 individuals","volume":"38","author":"Wulff","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"32","key":"10.1016\/j.ihj.2023.12.001_bib44","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.ihj.2023.12.001_bib45","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1161\/CIRCRESAHA.115.307609","article-title":"How an artery heals","volume":"117","author":"Williams","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.ihj.2023.12.001_bib46","series-title":"Lipid Modification: Cardiovascular Risk Assessment and the Modification of Blood Lipids for the Primary and Secondary Prevention of Cardiovascular Disease","year":"2014"},{"issue":"25","key":"10.1016\/j.ihj.2023.12.001_bib47","first-page":"e1082","article-title":"AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American heart association task force on clinical practice guidelines","volume":"139","author":"Grundy","year":"2018","journal-title":"Circulation"},{"issue":"24","key":"10.1016\/j.ihj.2023.12.001_bib48","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American heart association task force on clinical practice guidelines","volume":"73","author":"Grundy","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"10.1016\/j.ihj.2023.12.001_bib49","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1093\/eurheartj\/ehx549","article-title":"Update of ESC\/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin\/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia","volume":"39","author":"Landmesser","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ihj.2023.12.001_bib50","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.atherosclerosis.2019.12.005","article-title":"Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM","volume":"294","author":"Nordestgaard","year":"2020","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.ihj.2023.12.001_bib51","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacl.2020.01.006","article-title":"Proposed low-density lipoprotein cholesterol goals for secondary prevention and familial hypercholesterolemia in India with focus on PCSK9 inhibitor monoclonal antibodies: expert consensus statement from Lipid Association of India","volume":"14","author":"Puri","year":"2020","journal-title":"J Clin Lipidol"},{"issue":"1","key":"10.1016\/j.ihj.2023.12.001_bib52","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.amjcard.2011.03.003","article-title":"Comparisons of apolipoprotein B levels estimated by immunoassay, nuclear magnetic resonance, vertical auto profile, and non-high-density lipoprotein cholesterol in subjects with hypertriglyceridemia (SAFARI Trial)","volume":"108","author":"Grundy","year":"2011","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.ihj.2023.12.001_bib53","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jacl.2012.04.081","article-title":"Phenotypes of hypertriglyceridemia caused by excess very-low-density lipoprotein","volume":"6","author":"Sniderman","year":"2012","journal-title":"J Clin Lipidol"},{"issue":"2","key":"10.1016\/j.ihj.2023.12.001_bib54","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0022-2275(20)38008-1","article-title":"Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia","volume":"24","author":"Brunzell","year":"1983","journal-title":"J Lipid Res"},{"issue":"1","key":"10.1016\/j.ihj.2023.12.001_bib55","doi-asserted-by":"crossref","first-page":"7","DOI":"10.5334\/gh.882","article-title":"A comparison of lipids and apoB in Asian Indians and Americans","volume":"16","author":"Singh","year":"2021","journal-title":"Glob Heart"}],"container-title":["Indian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483223004704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483223004704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T21:51:22Z","timestamp":1731707482000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0019483223004704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":55,"alternative-id":["S0019483223004704"],"URL":"https:\/\/doi.org\/10.1016\/j.ihj.2023.12.001","relation":{},"ISSN":["0019-4832"],"issn-type":[{"value":"0019-4832","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Apolipoprotein B - An ideal biomarker for atherosclerosis?","name":"articletitle","label":"Article Title"},{"value":"Indian Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ihj.2023.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Cardiological Society of India. Published by Elsevier, a division of RELX India, Pvt. Ltd.","name":"copyright","label":"Copyright"}]}}